HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Cardiology World Conference

September 15-17, 2025 | London, UK

September 15 -17, 2025 | London, UK
Cardio 2025

Minimal invasive pediatric and adult congenital cardiac surgery

Y J H J Taverne, Speaker at Cardiovascular Conference
Erasmus University Medical Center, Netherlands
Title : Minimal invasive pediatric and adult congenital cardiac surgery

Abstract:

Full midline sternotomy remains the most common incision to correct congenital cardiac defects. Although many minimal invasive programs exist for the adult population worldwide, only a few centers have adopted such a program for the pediatric population. The rise of novel interventional cardiology techniques and the main advantages of earlier recovery and cosmesis, have prompted some groups to explore alternative approaches to median sternotomy. However, the steep learning curve and technical difficulties associated with minimally invasive procedures have discouraged many surgeons to opt for this approach as their new “gold standard”. Few reports have been published on starting such a program and in our opinion, the success is dependent on a step-by-step approach with attention to the full cycle of care. This includes preoperative awareness and screening to postoperative care where many reluctancies might be present based on inexperience and mostly fear of the unknown. We already have extensive minimal invasive surgical experience in the (congenital) adult population and used this knowledge when designing and developing the minimal invasive children’s program.

The presentation addresses specific conditions to correct minimally invasive, central cannulation possibilities, mid-axillary approach and optimal post-operative pain management. Minimal invasive pediatric surgeries are performed in our center starting from 5kg and encompass ASDII closure, partial abnormal venous return, partial AVSD to VSD closure without residual defects, no conversions and no other comorbidities. All cases were discharged around day 4 with a maximum stay of 1 night at the ICU. Pain management was optimized where early full mobilization was key.

Biography:

Dr. Y. Taverne currently work as a pediatric and adult congenital cardiothoracic surgeon and cardiac morphologist at the department of Cardiothoracic Surgery at the Erasmus MC, Rotterdam, The Netherlands. As a clinical epidemiologist and associate professor, he is leading the Translational Cardiothoracic Surgery Research Lab. His surgical focus encompasses minimally invasive (pediatric) procedures, cardiac transplantation including ex-situ heart perfusion, and Ross surgery. His research focusses on excitation-contraction coupling with strong interest in congenital heart disease (CHD) and heart failure. Current projects include RV form and function in (CHD), ex-situ heart perfusion and living myocardial slices in a biomimetic culture system.

Watsapp